Département de maladies infectieuses-médecine interne-dermatologie, CHU de La Réunion, Saint Pierre, La Réunion, France.
Santé Publique France, Océan Indien, Saint Denis, La Réunion, France.
BMC Infect Dis. 2023 Aug 2;23(1):506. doi: 10.1186/s12879-023-08432-4.
Dengue is an arboviral disease transmitted by the dengue virus, whose vectors are Aedes aegypti and Aedes albopictus. The acute phase with its cohort of well-known symptoms is usually spontaneously favorable. Since 2020 in Reunion Island, a new symptom has appeared: the ocular damage of dengue fever, which has already been described in South Asia and South-East Asia. We therefore decided to describe the clinical, biological, ophthalmological, therapeutic, and outcomes of patients with ocular manifestations during dengue fever in Reunion Island in 2020.
This was a retrospective observational study. Patients were included from January 2020 to August 2020 and then reassessed by teleconsultation 1 year later. The patients were identified from the French public health surveillance network by all ophthalmologists on the island. Medical data were collected directly from medical records.
Twenty-eight patients were included. The mean age was 41.9 years. Ocular involvement occurred approximately 9.2 days after the onset of dengue symptoms. The main symptoms were scotoma (71.4%) and sudden decrease of visual acuity (39.2%). Eighteen patients (64.2%) had macular involvement. Fourteen patients were treated with oral or intravenous corticosteroids. Twenty-two (78.5%) patients were evaluated by telephone one year later. Scotoma and decreased visual acuity persisted in 15 patients. Thirteen patients (59%) were bothered by night driving, 32% of patients had reading difficulties and 27% of patients became sensitive to prolonged exposure to screens.
Ocular complications of dengue require early and collegial management to limit the risk of long-term sequelae. Further studies on the characteristics and complications of dengue fever are needed to better understand this disease.
登革热是一种由登革病毒引起的虫媒病毒病,其传播媒介为埃及伊蚊和白纹伊蚊。通常情况下,急性登革热伴有一系列众所周知的症状,会自行好转。自 2020 年以来,在留尼汪岛出现了一种新的症状:登革热眼部损伤,这种症状已在南亚和东南亚有所描述。因此,我们决定描述 2020 年留尼汪岛登革热患者眼部表现的临床、生物学、眼科、治疗和结局。
这是一项回顾性观察性研究。2020 年 1 月至 8 月期间,所有岛上的眼科医生通过法国公共卫生监测网络对患者进行了识别,并通过电话对患者进行了 1 年的重新评估。从医疗记录中直接收集患者的医疗数据。
共纳入 28 例患者。平均年龄为 41.9 岁。眼部受累发生在登革热症状出现后约 9.2 天。主要症状为视野缺损(71.4%)和突发性视力下降(39.2%)。18 例(64.2%)患者存在黄斑受累。14 例患者接受了口服或静脉内皮质类固醇治疗。22 例(78.5%)患者在 1 年后通过电话进行了评估。15 例患者仍存在视野缺损和视力下降。13 例患者(59%)夜间开车困难,32%的患者阅读困难,27%的患者对长时间暴露在屏幕前敏感。
登革热的眼部并发症需要早期进行协作管理,以降低长期后遗症的风险。需要进一步研究登革热的特征和并发症,以更好地了解这种疾病。